Institute for Complementary and Integrative Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Faculty of Medicine, Universidad Francisco de Vitoria (UFV), Madrid, Spain.
PLoS One. 2024 Jul 8;19(7):e0306772. doi: 10.1371/journal.pone.0306772. eCollection 2024.
The objective of this meta-epidemiological study was to develop a rating that captures participants' motivation at the study level in digital health intervention (DHI) randomised controlled trials (RCTs). The rating was used to investigate whether participants' motivation is associated with the effect estimates in DHI RCTs for cancer patients. The development of the rating was based on a bottom-up approach involving the collection of information that captures participants' baseline motivation in empirical studies from the Smartphone-RCCT Database. We specified three indicators for rating: indicator 1 captures whether the study team actively selects or enhances the motivation of the potential study participants; indicator 2 captures the study participants' active engagement before the treatment allocation; and indicator 3 captures the potential bond and trust between the study participants and the person/institution referring to the study. The rating of each indicator and the overall rating varies between high motivation, moderate motivation, and low motivation. We applied the rating across 27 DHI RCTs with cancer patients. We performed meta-regression analysis to examine the effect of patient motivation on quality of life (QoL), psychological outcomes, and attrition. The intraclass correlation coefficient (ICC) indicated moderate to poor inter-rater reliability. The meta-regression showed that cancer patients' overall motivation before engaging in the intervention was associated with the treatment effect of QoL. Patient motivation was not found to be associated with psychological outcomes or attrition. Subgroup analyses revealed that the clinical effects of DHIs were more prevalent in the high-motivation subgroups, whereas the low-motivation subgroups were unlikely to show intervention benefits. The likelihood of dropouts from DHIs seems to be especially high among the low-bond (indicator 3) subgroup. We suggest using single indicators since they reflect specific content. Better reporting about baseline motivation is required to enable meaningful interpretations in not only primary studies but also in evidence syntheses.
本元流行病学研究的目的是开发一种评分,以捕捉数字健康干预(DHI)随机对照试验(RCT)中参与者的研究水平的动机。该评分用于研究癌症患者的 DHI RCT 中参与者的动机是否与效果估计值相关。评分的开发基于自下而上的方法,涉及从 Smartphone-RCCT 数据库中收集实证研究中参与者基线动机的信息。我们指定了三个评分指标:指标 1 捕捉研究团队是否积极选择或增强潜在研究参与者的动机;指标 2 捕捉治疗分配前研究参与者的积极参与;指标 3 捕捉研究参与者与研究负责人之间的潜在联系和信任。每个指标和总体评分的评分高低分别为高动机、中动机和低动机。我们将该评分应用于 27 项癌症患者的 DHI RCT。我们进行了荟萃回归分析,以研究患者动机对生活质量(QoL)、心理结果和失访的影响。组内相关系数(ICC)表明评分者间的可靠性为中等至较差。荟萃回归显示,参与干预前癌症患者的整体动机与 QoL 的治疗效果相关。患者动机与心理结果或失访无关。亚组分析表明,DHIs 的临床效果在高动机亚组中更为普遍,而低动机亚组不太可能显示干预效益。DHIs 的辍学率似乎在低关联(指标 3)亚组中尤其高。我们建议使用单一指标,因为它们反映了特定的内容。需要更好地报告基线动机,以便不仅在原始研究中,而且在证据综合中进行有意义的解释。